High Dose Vitamin D and MS Relapse: New Phase 3 Data
Data from a phase 3 trial suggest high-dose vitamin D does not prevent relapse in patients with RRMS. However, at least one expert suggests the study's exclusion criteria may have been too broad.
Stay updated with breaking news from Relapse Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data from a phase 3 trial suggest high-dose vitamin D does not prevent relapse in patients with RRMS. However, at least one expert suggests the study's exclusion criteria may have been too broad.
Here you have the breast cancer that you can see. the thing that is white is fat tissue and the cancer, it's all this stuff which is kind of purple. so, i can see all these details on the slide and check that the quality is good. and once i say, "ok, the quality is good," i send it to a server, where the ai is performed. and then, after that, i receive a report performed by the ai, telling me what is the relapse risk associated to this slide. and, after that, i can check the report and also see if, for me, the relapse risk is in accordance with what i saw on the microscope. by the nature of it...
That this will replace the importance of doctors, but the hope is that more detailed data and analysis could enhance theirjudgement calls. here you have the breast cancer that you can see. the thing that is white is fat tissue and the cancer, it's all this stuff which is kind of purple. so, i can see all these details on the slide and check that the quality is good. and once i say, "ok, the quality is good," i send it to a server, where the ai is performed. and then, after that, i receive a report performed by the ai, telling me what is the relapse risk associated to this slide. and, after tha...
Could enhance theirjudgement calls. here you have the breast cancer that you can see. the thing that is white is fat tissue and the cancer, it's all this stuff which is kind of purple. so, i can see all these details on the slide and check that the quality is good. and once i say, "ok, the quality is good," i send it to a server where the ai is performed. and then, after that, i receive a report performed by the ai, telling me what is the relapse risk associated to this slide. and, after that, i can check the report and also see if, for me, the relapse risk is in accordance with what i saw on ...
Theirjudgment calls. here you have the breast cancer that you can see. the thing that is white is fat tissue, and the cancer is all this stuff which is kind of purple. so i can see all these details on the slide and check that the quality is good. and once i say, "ok, the quality is good," i send it to a server where the ai is performed. and then, after that, i receive a report performed by the ai, telling me what is the relapse risk associated to this slide. and, after that, i can check the report and also see if, for me, the relapse risk is in accordance with what i saw on the microscope. by...